A metabolism-related radiomics signature for predicting the prognosis of colorectal cancer

Jan 7, 2021·
Du CAI
Du CAI
1st Author
Xin DUAN
Xin DUAN
Co-1st Author
,
Wei Wang
Ze-Ping HUANG
Ze-Ping HUANG
Qi-Qi ZHU
Qi-Qi ZHU
Min-Er ZHONG
Min-Er ZHONG
Min-Yi LV
Min-Yi LV
Cheng-Hang LI
Cheng-Hang LI
Wei-Bin KOU
Wei-Bin KOU
,
Xiao-Jian Wu
Co-corresponding Author
Feng GAO
Feng GAO
Corresponding Author
· 0 min read
Abstract

Background: Radiomics refers to the extraction of a large amount of image information from medical images, which can provide decision support for clinicians. In this study, we developed and validated a radiomics-based nomogram to predict the prognosis of colorectal cancer (CRC).

Methods: A total of 381 patients with colorectal cancer (primary cohort: n = 242; validation cohort: n = 139) were enrolled and radiomic features were extracted from the vein phase of preoperative computed tomography (CT). The radiomics score was generated by using the least absolute shrinkage and selection operator algorithm (LASSO). A nomogram was constructed by combining the radiomics score with clinicopathological risk factors for predicting the prognosis of CRC patients. The performance of the nomogram was evaluated by the calibration curve, receiver operating characteristic (ROC) curve and C-index statistics. Functional analysis and correlation analysis were used to explore the underlying association between radiomic feature and the gene-expression patterns.

Results: Five radiomic features were selected to calculate the radiomics score by using the LASSO regression model. The Kaplan-Meier analysis showed that radiomics score was significantly associated with disease-free survival (DFS) [primary cohort: hazard ratio (HR): 5.65, 95% CI: 2.26–14.13, P < 0.001; validation cohort: HR: 8.49, 95% CI: 2.05–35.17, P < 0.001]. Multivariable analysis confirmed the independent prognostic value of radiomics score (primary cohort: HR: 5.35, 95% CI: 2.14–13.39, P < 0.001; validation cohort: HR: 5.19, 95% CI: 1.22–22.00, P = 0.026). We incorporated radiomics signature with the TNM stage to build a nomogram, which performed better than TNM stage alone. The C-index of the nomogram achieved 0.74 (0.69–0.80) in the primary cohort and 0.82 (0.77–0.87) in the validation cohort. Functional analysis and correlation analysis found that the radiomic signatures were mainly associated with metabolism related pathways.

Conclusions: The radiomics score derived from the preoperative CT image was an independent prognostic factor and could be a complement to the current staging strategies of colorectal cancer.

Type
Publication
Frontiers in Molecular Biosciences
publication
Du CAI
Authors
Postdoc
I focus on leveraging explainable AI and large foundation models to advance medical imaging and digital pathology in colorectal cancer research.
Xin DUAN
Authors
Postdoc
I focus on medical image analysis and artificial intelligence for cancer research, including molecular subtyping and predictive modeling.
Ze-Ping HUANG
Authors
Medical Student
I am a medical trainee in colorectal surgery, focusing on bioinformatics and translational research in colorectal cancer.
Qi-Qi ZHU
Authors
Surgeon
I am a surgeon focusing on colorectal cancer and translational bioinformatics in clinical practice.
Min-Er ZHONG
Authors
Postdoc
I am a surgeon and clinical researcher focused on deep learning and translational studies in colorectal cancer.
Min-Yi LV
Authors
PhD Student
I am a PhD student at Guangzhou National Laboratory, focusing on colorectal cancer research, biostatistics, and evidence-driven clinical modeling.
Cheng-Hang LI
Authors
Research Assistant
I am a research assistant focusing on deep learning, multimodal feature fusion, and medical AI system development.
Wei-Bin KOU
Authors
Research Assistant
I focus on deep learning and computational pathology with a background in software engineering and AI development.
Feng GAO
Authors
Professor
My research leverages AI and big data to improve diagnostics, prognostics, and ultimately, outcomes in cancer and other biomedical fields.